Bend Research and Vertex Pharmaceutical enter new scientific collaboration
Bend Research to provide novel formulation development and manufacturing services for specific Vertex-led projects and clinical trials
Bend Research Inc. announced that it has entered into a collaboration with Vertex Pharmaceuticals Incorporated. Through this new collaboration, Vertex will utilize Bend’s formulation development and manufacturing services for specific projects and clinical trials, with the goals of both enhancing the delivery of Vertex compounds and supporting the progression of certain Vertex product candidates through clinical development.
The collaboration between Bend Research and Vertex is designed to leverage the fundamental scientific capabilities of each company to solve formulation and process-development challenges and to produce commercial drug products that are optimized for therapeutic benefit.
“It’s a great opportunity for both companies,” Bend Research CEO Rod Ray explained. “We are excited to be working with Vertex. We share their commitment to delivering breakthrough therapies based on cutting-edge science. Having two great teams working side by side is a powerful combination – we look forward to a long and fruitful relationship.”
Other news from the department business & finance
